Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1999;100:1499-1501

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correction (v100,p1940)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Timmermans, C.
Right arrow Articles by Wellens, H. J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Timmermans, C.
Right arrow Articles by Wellens, H. J. J.
Related Collections
Right arrow CPR and emergency cardiac care
Right arrow Other Treatment
Right arrow Arrhythmias, clinical electrophysiology, drugs

(Circulation. 1999;100:1499-1501.)
© 1999 American Heart Association, Inc.


Brief Rapid Communication

Use of Sedation During Cardioversion With the Implantable Atrial Defibrillator

Carl Timmermans, MD; Ashish Nabar, MD; Luz-Maria Rodriguez, MD; Gregory Ayers, MD; Hein J. J. Wellens, MD

From the Department of Cardiology, Academic Hospital Maastricht, Maastricht, The Netherlands.

Correspondence to Carl Timmermans, Department of Cardiology, Academic Hospital Maastricht, CARIM (Cardiovascular Research Institute Maastricht), P. Debyelaan 25, PO Box 5800, 6202 AZ Maastricht, The Netherlands. E-mail C.Timmermans{at}cardio.azm.nl

Background—The low shock energy used during internal atrial defibrillation may decrease the need for sedation during defibrillation with an implantable atrial defibrillator.

Methods and Results—The atrial defibrillator (Metrix Atrioverter) was implanted in 12 patients. During the in-hospital treatment of atrial fibrillation (AF) episodes, intravenous sedation was given only on patient request. The Atrioverter was programmed for ambulatory therapy in 4 patients. Efficacy, number of shocks delivered, and sedation requirements were recorded. A total of 393 shocks (1.8±1.6 shocks/AF episode) were delivered to treat 213 AF episodes; 85 of 213 AF episodes (40%) were treated away from the hospital. Sinus rhythm was restored in 195 AF episodes (92%). Five patients never requested sedation. No sedation was needed for ambulatory-treated AF episodes. During the treatment of 26 of 213 AF episodes (12%), 75 shocks were delivered after patients received sedation. The number of shocks required to treat an AF episode determined the need for sedation (4.3±2.1 shocks for AF episodes requiring sedation versus 2±1 shocks for AF episodes requiring no sedation; P<0.001). These additional shocks were needed to treat immediate reinitiation of AF (14 episodes) or initial failure to cardiovert (4 episodes). For 8 AF episodes, sedation was requested before the first shock.

Conclusions—This study suggests that, in a selected group of patients, AF can be treated with Atrioverter therapy without sedation. Successful ambulatory treatment of AF episodes with the Atrioverter, programmed to deliver <=2 shocks, did not require sedation. When multiple shocks were required to treat an AF episode, the need for sedation increased and included patients initially not requesting sedation.


Key Words: atrium • fibrillation • defibrillation




This article has been cited by other articles:


Home page
CirculationHome page
G. Manoharan, N. Evans, B. Kidwai, D. Allen, J. Anderson, and J. Adgey
Novel Passive Implantable Atrial Defibrillator Using Transcutaneous Radiofrequency Energy Transmission Successfully Cardioverts Atrial Fibrillation
Circulation, September 16, 2003; 108(11): 1382 - 1388.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
X. Zheng, M. E. Benser, G. P. Walcott, and R. E. Ideker
Right Atrial Septal Electrode for Reducing the Atrial Defibrillation Threshold
Circulation, August 28, 2001; 104(9): 1066 - 1070.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
R. H. Falk
Atrial Fibrillation
N. Engl. J. Med., April 5, 2001; 344(14): 1067 - 1078.
[Full Text] [PDF]


Home page
CirculationHome page
E. G. Daoud, C. Timmermans, C. Fellows, R. Hoyt, R. Lemery, K. Dawson, and G. M. Ayers
Initial Clinical Experience With Ambulatory Use of an Implantable Atrial Defibrillator for Conversion of Atrial Fibrillation
Circulation, September 19, 2000; 102(12): 1407 - 1413.
[Abstract] [Full Text] [PDF]